The DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.
Long fasting is effective in inhibiting physiological myocardial 18F-FDG uptake and for evaluating active lesions of cardiac sarcoidosis
Open accessAbstract
Background: F-fluorodeoxyglucose (FDG) positron emission tomography (PET) is a promising modality for detecting active lesions of cardiac sarcoidosis (CS). However, determining whether 18 F-FDG uptake in the myocardium is physiological is challenging due to metabolic shift in myocardial cells. Although methods for inhibiting physiological myocardial 18 F-FDG uptake have been proposed, no standard methods exist. This study therefore aimed to compare the effect of an 18-h fast (long fasting (LF)) with heparin loading plus a 12-h fast (HEP) before 18 F-FDG PET scan. Methods: We analyzed the effects of LF and HEP on the inhibition of physiological myocardial 18 F-FDG uptake in healthy subjects (18 in HEP and 19 in LF) and in patients with known or suspected CS (96 in HEP and 69 in LF). In CS, the lower uptake of 18 F-FDG in the myocardium was evaluated. A visual four-point scale was used to assess myocardial 18 F-FDG uptake in comparison with hepatic uptake (1 lower, 2 similar, 3 somewhat higher, 4 noticeably higher). Results: Myocardial 18 F-FDG uptake was 1.68 ± 1.06 in LF and 3.17 ± 1.16 in HEP in healthy subjects (p < 0.0001), whereas it was 1.48 ± 0.99 in LF and 2.48 ± 1.33 in HEP in CS patients (p < 0.0001). Logistic regression and regression trees revealed the LF was the most effective in inhibiting myocardial 18 F-FDG uptake. In addition, serum free fatty acid levels on intravenous 18 F-FDG injection were a possible biomarker. Conclusions: LF is effective in inhibiting myocardial 18 F-FDG uptake, and consequently, it could be useful for evaluating active lesions of CS in 18 F-FDG PET images.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Boden, G. (2003) · Experimental and Clinical Endocrinology & Diabetes · doi:10.1055/s-2003-39781 · Cited by 348 · cited 1×
“maintained, they cause peripheral (muscle) insulin resistance, inhibiting insulin-stimulated glucose uptake and glycogen synthesis [21-23].”
Background
Cited by
JCS 2016 Guideline on Diagnosis and Treatment of Cardiac Sarcoidosis ― Digest Version ―
Terasaki, F., Azuma, A., Anzai, T., Ishizaka, N., Ishida, Y., Isobe, M., Inomata, T., Ishibashi-Ueda, H., Eishi, Y., Kitakaze, M., et al. (2019) · Circulation Journal · doi:10.1253/circj.cj-19-0508 · Cited by 479
Self-citationPET imaging of inflammation in atherosclerosis
Tarkin, J. M., Joshi, F. R., & Rudd, J. H. F. (2014) · Nature Reviews Cardiology · doi:10.1038/nrcardio.2014.80 · Cited by 386
Chareonthaitawee, P., Beanlands, R. S., Chen, W., Dorbala, S., Miller, E. J., Murthy, V. L., Birnie, D. H., Chen, E. S., Cooper, L. T., Tung, R. H., et al. (2017) · Journal of Nuclear Medicine · doi:10.2967/jnumed.117.196287 · Cited by 300
Cardiac sarcoidosis: state-of-the-art review
Kouranos, V., & Sharma, R. (2021) · Heart · doi:10.1136/heartjnl-2019-316442 · Cited by 259
Chareonthaitawee, P., Beanlands, R. S., Chen, W., Dorbala, S., Miller, E. J., Murthy, V. L., Birnie, D. H., Chen, E. S., Cooper, L. T., Tung, R. H., et al. (2017) · Journal of Nuclear Cardiology · doi:10.1007/s12350-017-0978-9 · Cited by 254
Metadata
- Authors
- Morooka, M., Moroi, M., Uno, K., Ito, K., Wu, J., Nakagawa, T., Kubota, K., Minamimoto, R., Miyata, Y., Okasaki, M., Okazaki, O., Yamada, Y., Yamaguchi, T., & Hiroe, M.
- Venue
- EJNMMI Research
- Published
- 2014-01-02
- Volume
- 4
- Issue
- 1
- Pages
- 1-1
- ISSN
- 2191-219X (ISSN-L)
- OpenAlex
- W2129843482
- Cited by
- 160
- References
- 1
- FWCI
- 14.77
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Long fasting is effective in inhibiting physiological myocardial 18F-FDG uptake and for evaluating active lesions of cardiac sarcoidosis. https://app.cochat.ai/papers/10.1186/2191-219x-4-1
- The paper
- Morooka, M., Moroi, M., Uno, K., Ito, K., Wu, J., Nakagawa, T., Kubota, K., Minamimoto, R., Miyata, Y., Okasaki, M., Okazaki, O., Yamada, Y., Yamaguchi, T., & Hiroe, M. (2014). Long fasting is effective in inhibiting physiological myocardial 18F-FDG uptake and for evaluating active lesions of cardiac sarcoidosis. EJNMMI Research. https://doi.org/10.1186/2191-219x-4-1
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.